These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 16216107

  • 1. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
    Luzzati R, Allegranzi B, Antozzi L, Masala L, Pegoraro E, Azzini A, Concia E.
    Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
    [Abstract] [Full Text] [Related]

  • 2. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C.
    J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study.
    Gürcüoğlu E, Ener B, Akalin H, Sinirtaş M, Evci C, Akçağlar S, Yilmaz E, Heper Y.
    Epidemiol Infect; 2010 Sep; 138(9):1328-35. PubMed ID: 20056017
    [Abstract] [Full Text] [Related]

  • 4. Nosocomial candidaemia in children: results of a 9-year study.
    Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G.
    Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
    [Abstract] [Full Text] [Related]

  • 5. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital.
    Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A.
    Mycoses; 2006 Mar; 49(2):134-8. PubMed ID: 16466448
    [Abstract] [Full Text] [Related]

  • 6. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A, van Rhee F, Henslee-Downey JP, Singhal S, Mehta J.
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [Abstract] [Full Text] [Related]

  • 7. Effect of fluconazole consumption on long-term trends in candidal ecology.
    Blot S, Janssens R, Claeys G, Hoste E, Buyle F, De Waele JJ, Peleman R, Vogelaers D, Vandewoude K.
    J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
    [Abstract] [Full Text] [Related]

  • 8. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
    Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T.
    Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324
    [Abstract] [Full Text] [Related]

  • 9. Candida glabrata fungaemia in intensive care units.
    Ruan SY, Lee LN, Jerng JS, Yu CJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [Abstract] [Full Text] [Related]

  • 10. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W, Morton A, Eisen DP.
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F, Esposito R.
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
    Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Täuber MG, Pittet D, Fungal Infection Network of Switzerland.
    Clin Infect Dis; 2004 Feb 01; 38(3):311-20. PubMed ID: 14727199
    [Abstract] [Full Text] [Related]

  • 14. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors.
    Boo TW, O'reilly B, O'leary J, Cryan B.
    Mycoses; 2005 Jul 01; 48(4):251-9. PubMed ID: 15982207
    [Abstract] [Full Text] [Related]

  • 15. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
    Presterl E, Daxböck F, Graninger W, Willinger B.
    Clin Microbiol Infect; 2007 Nov 01; 13(11):1072-6. PubMed ID: 17725647
    [Abstract] [Full Text] [Related]

  • 16. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.
    Dizbay M, Fidan I, Kalkanci A, Sari N, Yalcin B, Kustimur S, Arman D.
    Scand J Infect Dis; 2010 Nov 01; 42(2):114-20. PubMed ID: 19883150
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrel M, Fraser VJ, Kollef MH.
    Crit Care Med; 2007 Apr 01; 35(4):1077-83. PubMed ID: 17312565
    [Abstract] [Full Text] [Related]

  • 19. Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.
    Playford EG, Nimmo GR, Tilse M, Sorrell TC.
    J Hosp Infect; 2010 Sep 01; 76(1):46-51. PubMed ID: 20382444
    [Abstract] [Full Text] [Related]

  • 20. Nosocomial candidaemia in a Finnish tertiary care centre during 1987-2004.
    Poikonen E, Lyytikäinen O, Anttila VJ, Kuusela P, Koukila-Kähkölä P, Ollgren J, Ruutu P.
    Scand J Infect Dis; 2009 Sep 01; 41(8):590-6. PubMed ID: 19488931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.